Trial intelligence / Profile preview

Stannous Fluoride Dentifrice for Gingivitis

NCT02750943Completed

Sponsor
GSK
Start
Nov 2015
Primary completion
Mar 2016
Modality
DNA Intercalators/Alkylators
Countries
1
01

Overview

Randomised, single-blind trial of stannous fluoride in gingivitis (2 arms), sponsored by GSK. Primary endpoint: Number of Bleeding Sites at 12 weeks. Started Nov 2015; status: completed.

02

Drugs

stannous fluoride
03

Conditions

gingivitis

Beyond the preview

Go deeper on NCT02750943.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02750943.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call